Herbert Timothy P.'s Form 4/A amendment
AmendedInspire Medical Systems, Inc. (INSP) · filed Mar 13, 2023
- Accession no.
- 0001104659-23-031817
- Filed
- Mar 13, 2023
- Trade date
- Mar 29, 2022
- Filing delay
- 349 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Mar 29, 2022
This filing lists 4 non-derivative transactions. It carries over 6 transactions from the original filing that it did not restate. Open-market sales total $29.3M. It was filed 349 days after the trade.
This amendment restates part of 0001104659-22-039633 (filed Mar 29, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Herbert Timothy P.CIK 0001737136 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 | Common Stock | SSaleDisposed | −74,315 | $250.20F2 | −$18,593,613 | 40,990 | Indirect | |
| Mar 29, 2022 | Common Stock | SSaleDisposed | −13,619 | $251.06F5 | −$3,419,186.14 | 105,123 | Indirect | |
| Mar 29, 2022 | Common Stock | SSaleDisposed | −1,465 | $251.92F8 | −$369,062.8 | 103,658 | Indirect | |
| Mar 29, 2022 | Common Stock | SSaleDisposed | −8,017 | $252.39F9 | −$2,023,410.63 | 106,773 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001104659-22-039633 (filed Mar 29, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2022 | Common Stock | SSaleDisposed | −695 | $250.00 | −$173,750 | 120,455 | Direct | |
| Mar 28, 2022 | Common Stock | SSaleDisposed | −1,546 | $250.00F2 | −$386,500 | 118,909 | Direct | |
| Mar 25, 2022 | Common Stock | SSaleDisposed | −42 | $250.00 | −$10,500 | 122,833 | Indirect | |
| Mar 28, 2022 | Common Stock | SSaleDisposed | −2,542 | $250.00F7 | −$635,500 | 120,291 | Indirect | |
| Mar 29, 2022 | Common Stock | SSaleDisposed | −6,280 | $251.41F9 | −$1,578,854.8 | 31,302 | Indirect | |
| Mar 29, 2022 | Common Stock | SSaleDisposed | −8,427 | $252.37F10 | −$2,126,721.99 | 22,875 | Indirect |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.01. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.01 to $251.85. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.095 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4 amends and restates the previously reported sale transactions made by the Margaret C. Herbert 2018 Family Irrevocable GST Trust that occurred on March 29, 2022 in order to re-allocate such sales between three different sellers that are considered beneficially owned by the Reporting Person.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.78. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Margaret C. Herbert 2018 Family Irrevocable GST Trust, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sales by such trust on March 29, 2022 by 23,101 shares, which is corrected herein.
- F4
Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.78 to $251.77. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The amount of securities listed in Column 5 reflects the total shares held following the transaction based on reference to the total reported in the Reporting Person's Form 4/A related to transactions originally reported on March 21, 2022 and that was filed on March 13, 2023.
- F7
Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.85 to $252.10. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.10 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.